Artemis Hospitals

artemishospitals.com

Artemis Hospitals is a healthcare venture, launched in 2007, by the promoters of the Apollo Tyres Group. Artemis is the first hospital in Gurgaon to be accredited by JCI and NABH. Designed as one of the most advanced in India, Artemis provides an in-depth expertise in the sphere of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis aims to provide excellent medical care in a compassionate environment and a practice dedicated to pioneering research, empowering the health care professionals and the diverse communities we serve. The clinical procedures followed in the hospital are technologically advanced and supervised by distinguished doctors of international repute. Our endeavor to deliver standard-setting medical care is lead by the needs of the patient; our exceptional medical facilities and unmatched responsiveness has made us one of the most revered hospitals in the country.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

ITM RECEIVES EQUITY INVESTMENT OF EUR 25 MILLION FROM STRATEGIC PARTNER GRAND PHARMA

ITM Isotope Technologies Munich SE | February 17, 2022

news image

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company and Grand Pharmaceutical Group Limited (GP), a diversified global pharmaceutical company listed in Hong Kong, today announced that ITM and a subsidiary of GP have entered into a definitive agreement under which GP will make a EUR 25 million (USD 28 million) equity investment in ITM. The agreement will further deepen the strategic collaboration between the two companies and support ITM to further expanding its...

Read More

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

news image

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More

Pharma Tech

AMERISOURCEBERGEN PARTNERS WITH CHRONICLED TO OPTIMIZE PHARMACEUTICAL CHARGEBACK ACCURACY USING BLOCKCHAIN-POWERED TECHNOLOGY

AmerisourceBergen | April 22, 2022

news image

Global healthcare company AmerisourceBergen announced its partnership with Chronicled, the administrator of the MediLedger Network, to leverage a new blockchain-powered solution designed to enhance pharmaceutical chargeback accuracy and significantly reduce chargeback rejections. The blockchain solution will allow AB to streamline and optimize the complex process of pharmaceutical chargebacks while creating greater connectivity for its suppliers and customers. Over the past three years, AB has c...

Read More

Business Insights, PHARMACY MARKET

TETRIS PHARMA SIGNS SERVICE AGREEMENT WITH SYNEOS HEALTH

Tetris Pharma Ltd | December 13, 2022

news image

Tetris Pharma Ltd a subsidiary of biopharmaceutical company, Arecor Therapeutics plc announces that it has signed a service agreement with Syneos Health® the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, to support the build out of Tetris Pharma’s commercial platform across Europe. Through this partnership, Syneos Health will provide commercial support through an outsourced contract sales services to accelera...

Read More
news image

Business Insights

ITM RECEIVES EQUITY INVESTMENT OF EUR 25 MILLION FROM STRATEGIC PARTNER GRAND PHARMA

ITM Isotope Technologies Munich SE | February 17, 2022

ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company and Grand Pharmaceutical Group Limited (GP), a diversified global pharmaceutical company listed in Hong Kong, today announced that ITM and a subsidiary of GP have entered into a definitive agreement under which GP will make a EUR 25 million (USD 28 million) equity investment in ITM. The agreement will further deepen the strategic collaboration between the two companies and support ITM to further expanding its...

Read More
news image

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More
news image

Pharma Tech

AMERISOURCEBERGEN PARTNERS WITH CHRONICLED TO OPTIMIZE PHARMACEUTICAL CHARGEBACK ACCURACY USING BLOCKCHAIN-POWERED TECHNOLOGY

AmerisourceBergen | April 22, 2022

Global healthcare company AmerisourceBergen announced its partnership with Chronicled, the administrator of the MediLedger Network, to leverage a new blockchain-powered solution designed to enhance pharmaceutical chargeback accuracy and significantly reduce chargeback rejections. The blockchain solution will allow AB to streamline and optimize the complex process of pharmaceutical chargebacks while creating greater connectivity for its suppliers and customers. Over the past three years, AB has c...

Read More
news image

Business Insights, PHARMACY MARKET

TETRIS PHARMA SIGNS SERVICE AGREEMENT WITH SYNEOS HEALTH

Tetris Pharma Ltd | December 13, 2022

Tetris Pharma Ltd a subsidiary of biopharmaceutical company, Arecor Therapeutics plc announces that it has signed a service agreement with Syneos Health® the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, to support the build out of Tetris Pharma’s commercial platform across Europe. Through this partnership, Syneos Health will provide commercial support through an outsourced contract sales services to accelera...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us